A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely adopted? A dose of buprenorphine, an opioid that can help treat addiction to ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s tirzepatide (Mounjaro, Zepbound) have dominated headlines for their blockbuster ...

Today, much of the conversation around opioid use focuses on ways to more tightly control access, including limits on usage and the mandatory use of databases that can alert physicians to patients’ ...

Opioids relieve pain but are dangerous and highly addictive. In a recent 12-month period, there were 109,600 USA drug-overdose deaths, with 70% linked to opioids. In 2023, 5.7 million people in the ...

NIH-funded study demonstrates life-saving potential of providing medications for opioid use disorder in carceral settings A study supported by the National Institutes of Health (NIH) finds that ...

Food and Drug Administration Commissioner Scott Gottlieb, MD, said during his remarks to the House Committee on Energy and Commerce on Wednesday the FDA plans to expand the use of medications such as ...

Last week, the Trump administration released a five-step plan to address the country’s opioid addiction crisis. The administration’s new drug czar’s plan focuses largely on attempts to prevent ...

Specialized hospital services that aid people with opioid use disorder regardless of why they are admitted can boost the number of patients who begin treatment with FDA-approved medication for opioid ...

Medicaid is the largest payer of substance use disorder treatment in the US, 8 covering approximately 38 percent of nonelderly adults with OUD as of 2019. 9 The Substance Use Disorder Prevention that ...